Our Products
Oncology
HALAVEN
eribulin
(mBC, Soft
tissue Sarcoma)
LENVIMA
Lenvatinib
(DTC, RCC,
HCC)
Neurology
FYCOMPA
perampanel
(Partial-onset seizure /primary generalized tonic-clonic seizures)
The Company also plans to launch an innovative drug, Dayvigo to treat insomnia, after obtaining all the regulatory and marketing approvals from the concerned authorities.
*Disclaimer - The product related information contained on this website is for educational purposes only and is not a substitute for the advice of the physician nor recommendation for any particular treatment plan. Please consult your physician before using any product mentioned on this website. For complete information on the products please refer to full prescribing information.
